Article Sidebar

Submitted
March 27, 2019
Accepted
August 20, 2019
Published
August 30, 2019
Download
PDF Cover letter Ethical Clearance COI Disclosure
Statistic
Read Counter : 781 Download : 558

Main Article Content

Abstract

Background: Cytokine Interleukin (IL) 1ß is increased in synovial fluid and cartilage of patients with osteoarthritis (OA). Curcuminoid blocks lipopolysaccharides causing the suppression of IL 1ß production. The capability of curcuminoid to decrease IL 1ß secretion by the synovial fluid monocytes has not been previously studied.
Objective: This study aimed to explore the activity of curcuminoid of turmeric rhizome extract (C. domestica Val.) in blocking the IL 1ß secretion by the knee synovial fluid monocytes of patients with osteoarthritis.
Methods: This research was a prospective randomized open and blinded endpoint (PROBE) study. The subjects of the study were osteoarthritis patients who were divided into 2 groups. Subjects were administered 30 mg of turmeric rhizome curcuminoid extract (treatment group) and 25 mg diclofenac sodium capsules (control group) twice a day for 4 weeks. Knee synovial fluid was taken before and after treatment. The capability examination of IL 1ß secretion by synovial fluid monocytes was conducted by culturizing the monocyte cells. Level of IL 1ß was measured by ELISA
Results: There were 80 subjects eligible to participate in the study according to the inclusion/exclusion criteria. The decrease of means of IL 1ß concentration of the curcuminoid group after the 4-week therapy was 70.24±81.46 pg/ml, while the decrease of means of diclofenac sodium was 61.90±60.42 pg/ml, with no significant difference between groups (p=0.691;95%CI:0.681-0.699).
Conclusion: Curcuminoid of turmeric rhizome (C. domestica Val.) extract has the capability which is not weaker than that with diclofenac sodium in decreasing the IL 1ß secretion by synovial fluid monocytes of the OA patients’ joints.

 

Keywords

C. domestica Val. interleukin 1ß synovial fluid

Article Details

Author Biography

Woro Rukmi Pratiwi, Department of Pharmacology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta

Sinta Profile: http://sinta2.ristekdikti.go.id/authors/detail?id=6048695&view=overview
How to Cite
Pratiwi, W. R., & Kertia, N. (2019). The effect of curcuminoid turmeric rhizome extract on interleukin 1ß concentration in osteoarthritis patient. JKKI : Jurnal Kedokteran Dan Kesehatan Indonesia, 10(2), 162–170. https://doi.org/10.20885/JKKI.Vol10.Iss2.art8
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Klippel J. Primer on the rheumatic diseases. 12th ed. Georgia: Arthritis Foundation; 2001. p. 573–582.
  2. Loeser R. Pathogenesis of osteoarthritis [Internet]. Up to date. 2018 [cited 2019 Aug 15]. Available from: www.uptodate.com/contents/table-of-contents/rheumatology/osteoarthritis
  3. Johnson VL, Hunter DJ. The epidemiology of osteoarthritis. Best Practise Research Clinical Rheumatology . 2014;28(1):5–15.
  4. IRA. Rekomendasi IRA untuk diagnosis dan penatalaksanaan osteoartritis. Jakarta: Ikatan Reumatologi Indonesia; 2014.
  5. WHO. Osteoarthritis. In: Priority medicines for Europe and the World 2013 Update. Geneva: World Health Organization; 2013.
  6. Hunter DJ, Bierma-zeinstra S. Osteoarthritis. Lancet. 2019;393:1745–59.
  7. Noormartany. Gambaran petanda biologi cairan tubuh pada penyakit osteoartritis. In: Pramudito R, Wachjudi R, Hamijoyo L, editors. Osteoarthritis Course. Bandung; 2005. p. 9–13.
  8. Lopes EBP, Filiberti A, Husain SA, Humphrey MB. Immune contributions to osteoarthritis. Current Osteoporosis Report. 2017;1–8.
  9. Bay-jensen AC, Thudium CS, Mobasheri A. Development and use of biochemical markers in osteoarthritis?: Current update. Current Opinion in Rheumatology. 2017;29:1–8.
  10. NPC. Management of acute pain and chronic noncancer pain. In: Pain: Current understanding of assessment, management, and treatments. Washington: National Pharmaceutical Council; 2005. p. 61–71.
  11. Depkes. Pedoman penggunaan obat opioit dalam penatalaksanaan nyeri. Jakarta: Departemen Kesehatan RI Direktorat Jendral Pelayanan Kefarmasian dan Alat Kesehatan Jakarta; 2002. p. 42–61.
  12. Shep D, Khanwelkar C, Gade P, Karad S. Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis?: A randomized open-label parallel-arm study. Trials. 2019;20(214):1–11.
  13. Yin H, Guo Q, Li X, Tang T, Li C, Wang H. Curcumin suppresses IL-1 ß secretion and prevents inflammation through inhibition of the NLRP3 inflammasome. The Journal of Immunology. 2018;200:2835–46.
  14. Tateiwa D, Yoshikawa H, Kaito T. Cartilage and bone destruction in arthritis?: pathogenesis and treatment strategy?: A literature review. Cells. 2019;8(818):1–31.
  15. Van Dalen SC, Blom AB, Walgreen B, Sloetjes AW, Helsen MM, Geven EJ. IL-1 ß -mediated activation of adipose-derived mesenchymal stromal cells results in PMN reallocation and enhanced phagocytosis?: A possible mechanism for the reduction of osteoarthritis pathology. Frontiers in Immunology. 2019;10(1075):1–13.
  16. Kertia N, Sudarsono, Imono A, Mufrod, Catur E, Rahardjo P. Pengaruh pemberian minyak atsiri temulawak dan ekstrak kunyit dibandingkan dengan piroksikam terhadap angka lekosit cairan sinovia penderita osteoarthritis lutut. Majalah Farmasi Indonesia. 2005;16:155–61.
  17. Ahmed S, Anuntiyo J, Malemud C, Haqqi T. Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: A review. Evidence-Based Complementary and Alternative Medicine. 2005;2:301–8.
  18. WHO. WHO monographs on selected medicinal plants. 1999. 115–124 p.
  19. Zhang Z, Luo D, Xie J, Xian Y, Lai Z, Liu Y. Curcumin’s metabolites, tetrahydrocurcumin and octahydrocurcumin, possess superior anti-inflammatory effects in vivo through suppression of TAK1-NF-?B pathway. Frontiers in Immunology. 2018;9(1181):1–12.
  20. Kumar SSD, Houreld NN, Abrahamse H. Therapeutic potential and recent advances of curcumin in the treatment of aging-associated diseases. Molecules. 2018;23(835):1–14.
  21. Soleimani V, Sahebkar A, Hosseinzadeh H. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review. Phytotherapy Research. 2018;1–11.
  22. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: Lessons learned from clinical trials. Journal of the American Association of Pharmaceutical Scientists. 2013;15:195–218.
  23. Westacott C, Wicher J, Barner I, Thompson D, Swan A, Dieppe P. Synovial fluid concentration of five differents cytokines in rheumatic disease. Annals of the Rheumatic Diseases. 1999;49:676–81.
  24. Srivastava S, Saksena AK, Khattri S, Kumar S, Dagur RS. Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee?: A four-month , double-blind , randomized , placebo-controlled trial. Inflammopharmacology. 2016;
  25. Barcelos RP, Bresciani G, Cuevas MJ, Martínez-flórez S, Soares FAA, Gozalez-Gallego J. Diclofenac pretreatment modulates exercise-induced inflammation in skeletal muscle of rats through the TLR4 / NF-?B pathway. Applied Physiology, Nutrition, and Metabolism. 2017;42(7):757–64.
  26. Kim L, Kim JY. Chondroprotective effect of curcumin and lecithin complex in human chondrocytes stimulated by IL-1 b via an anti- inflammatory mechanism. Food Sci ence and Biotechnology. 2019;28(2):547–53.
  27. Zhang Y, Zeng Y. Curcumin reduces inflammation in knee osteoarthritis rats through blocking TLR4 / MyD88 / NF- ? B signal pathway. Drug Development and Research. 2019;1–7.
  28. Wang J, Ma J, Gu JH, Wang F-Y, Shang X-S, Tao H-R. Regulation of type II collagen, matrix metalloproteinase-13 and cell proliferation by interleukin-1 ß is mediated by curcumin via inhibition of NF- ? B signaling in rat chondrocytes. Molecular Medicine Reports. 2017;16:1837–45.
  29. Henrotin Y, Priem F, Mobasheri A. Curcumin?: A new paradigm and therapeutic opportunity for the treatment of osteoarthritis?: Curcumin for osteoarthritis management. Springerplus. 2013;2(56):1–9.
  30. Cooper C, Kanis JA, Pavelka K, Bruye O, Leeb BF, Maheu E. Diacerein?: Benefits , risks and place in the management of osteoarthritis . An opinion-based report from the ESCEO. Drugs Aging. 2016;33:75–85.
  31. Bigoni M, Sacerdote P, Turati M, Franchi S, Gandolla M, Gaddi D. Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury. Journal of Orthopaedic Research. 2012;1–7.
  32. Hudiyanti V, Kertia N, Sumardi. Effect of curcuminoid versus diclofenac sodium on monocytes secretion of tumor necrosis factor a in knee osteoarthritis. Acta Interna - The Journal of Internal Medicine. 2012;2(1): 27-32.
  33. Kertia N, Asdie AH, Rochmah W Marsetyawan. Ability of curcuminoid from Curcuma domestica Val. in reducing the secretion of reactive oxygen intermediates by synovial fluid monocytes in patients with osteoarthritis. The Indonesian Journal of Biotechnology. 2011;16(1):111-7